Assenagon Asset Management’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $21.5M | Buy |
|
|||||
|
2025
Q2 | $6.06M | Sell |
|
|||||
|
2025
Q1 | $6.87M | Buy |
|
|||||
|
2024
Q4 | $6.02M | Sell |
|
|||||
|
2024
Q3 | $10M | Buy |
|
|||||
|
2024
Q2 | $3.57M | Buy |
|
|||||
|
2024
Q1 | $3.31M | Buy |
|
|||||
|
2023
Q4 | $893K | Sell |
|
|||||
|
2023
Q3 | $2.17M | Buy |
|
|||||
|
2023
Q2 | $718K | Sell |
|
|||||
|
2023
Q1 | $373K | Buy |
|
|||||
|
2022
Q4 | $144K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $158K | Hold |
|
|||||
|
2021
Q2 | $151K | Sell |
|
|||||
|
2021
Q1 | $1.65M | Sell |
|
|||||
|
2020
Q4 | $1.13M | Buy |
|
|||||
|
2020
Q3 | $72K | Sell |
|
|||||
|
2020
Q2 | $3.07M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $164K | Sell |
|
|||||
|
2019
Q3 | $971K | Buy |
|